These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38433502)

  • 1. Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase.
    Tishova Y; Kalinchenko S; Mskhalaya G; Hackett G; Livingston M; König C; Strange R; Zitzmann M; Mann A; Maarouf A; Ramachandran S
    Diabetes Obes Metab; 2024 Jun; 26(6):2147-2157. PubMed ID: 38433502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
    Aversa A; Bruzziches R; Francomano D; Rosano G; Isidori AM; Lenzi A; Spera G
    J Sex Med; 2010 Oct; 7(10):3495-503. PubMed ID: 20646185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
    Gopal RA; Bothra N; Acharya SV; Ganesh HK; Bandgar TR; Menon PS; Shah NS
    Endocr Pract; 2010; 16(4):570-6. PubMed ID: 20150021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P;
    J Sex Med; 2014 Mar; 11(3):840-56. PubMed ID: 24308723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
    Kapoor D; Goodwin E; Channer KS; Jones TH
    Eur J Endocrinol; 2006 Jun; 154(6):899-906. PubMed ID: 16728551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
    Hackett G
    Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone therapy over 60 months improves aging male symptoms scores in all men with adult-onset testosterone deficiency.
    Haider KS; Zitzmann M; Ramachandran P; König CS; Hackett G; Haider A; Saad F; Desnerck P; Strange R; Mann A; Ramachandran S
    Aging Male; 2024 Dec; 27(1):2357548. PubMed ID: 38812251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
    Groti K; Žuran I; Antonič B; Foršnarič L; Pfeifer M
    Aging Male; 2018 Sep; 21(3):158-169. PubMed ID: 29708829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
    Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
    Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism.
    Naharci MI; Pinar M; Bolu E; Olgun A
    Endocr Pract; 2007 Oct; 13(6):629-35. PubMed ID: 17954419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.
    Reddy KC; Yadav SB
    J Postgrad Med; 2021; 67(2):67-74. PubMed ID: 33942770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.
    Chillarón JJ; Fernández-Miró M; Albareda M; Fontserè S; Colom C; Vila L; Pedro-Botet J; Flores Le-Roux JA
    Endocr J; 2016 Sep; 63(9):849-855. PubMed ID: 27452372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome.
    Aversa A; Bruzziches R; Francomano D; Spera G; Lenzi A
    J Endocrinol Invest; 2010 Dec; 33(11):776-83. PubMed ID: 20220293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.
    Dimitriadis GK; Randeva HS; Aftab S; Ali A; Hattersley JG; Pandey S; Grammatopoulos DK; Valsamakis G; Mastorakos G; Jones TH; Barber TM
    Endocrine; 2018 Apr; 60(1):175-184. PubMed ID: 29396841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.